B. PACKAGE LEAFLET
the menopause • You have had muscle weakness with this or other steroids in the past • You have raised eye pressure (glaucoma) or there is a family history of glaucoma • You have a stomach (peptic) ulcer • You have mental problems or you have had a mental illness which was made worse by this type of
Download B. PACKAGE LEAFLET
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
Package leaflet: Information for the user Clexane …
www.medicines.org.uk1 Package leaflet: Information for the user. Clexane® Syringes 2,000 IU (20 mg)/0.2 ml solution for injection in pre-filled syringes . Clexane® Syringes 4,000 IU (40 mg)/0.4 ml solution for injection in pre-filled syringes
small pharma code may appear on the front / back …
www.medicines.org.ukKeep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the blister and carton after EXP.
PACKAGE LEAFLET: INFORMATION FOR THE USER
www.medicines.org.uk1.3.1. Package Leaflet 1 PACKAGE LEAFLET: INFORMATION FOR THE USER CALCEOS 500mg/400IU CHEWABLE TABLETS …
Information, User, Leaflet, Packages, Package leaflet, Information for the user
PACKAGE LEAFLET: INFORMATION FOR THE USER
www.medicines.org.uk1.3.1 Package Leaflet 1 Package leaflet: Information for the patient Laxido Orange, powder for oral solution. Read all of this leaflet carefully before you start taking this medicine because it contains
Information, User, Leaflet, Packages, Package leaflet, Information for the user, Information for the
Package leaflet: Information for the user - Medicines
www.medicines.org.ukPage 1 of 8 v019_0 Due to regulatory changes, the content of the following Patient Information Leaflet may vary from the one found in your medicine pack.
Package leaflet: Information for the user …
www.medicines.org.ukRead all of this leaflet carefully before you start taking this medicine because it contains important information for you. • Keep this leaflet.
PFIZER Package leaflet: Information for the patient …
www.medicines.org.ukPage 1 of 20 PFIZER Package leaflet: Information for the patient Depo-Provera® 150 mg/ml Sterile Suspension for Injection Medroxyprogesterone acetate Please read all of this leaflet carefully before you start using this medicine because it
Information, Leaflet, Packages, Pfizer, Information for the, Depo, Pfizer package leaflet
SAYANA PRESS 104 mg/0.65 ml suspension for …
www.medicines.org.ukPage 1 of 15 Package leaflet: Information for the user SAYANA PRESS® 104 mg/0.65 ml suspension for injection medroxyprogesterone acetate Single-dose container ...
Single, Dose, Injection, Acetate, Suspension, Medroxyprogesterone, Suspension for injection medroxyprogesterone acetate single dose
PACKAGE LEAFLET: INFORMATION FOR THE USER …
www.medicines.org.ukPACKAGE LEAFLET: INFORMATION FOR THE USER Bisoprolol 2.5 mg Film-coated Tablet Bisoprolol 5 mg Film-coated Tablet Bisoprolol 10 mg Film-coated Tablet
Patient Information Leaflet - Medicines
www.medicines.org.ukPage 2 of 10 Patient Information Leaflet Salazopyrin® EN-tabs 500 mg enteric-coated tablets sulfasalazine In this leaflet: 1. What Salazopyrin EN …
Related documents
Guidance on Menopause and the Workplace V6
www.fom.ac.uk13. Menopause and work: an electronic survey of employees attitudes Griffiths, MacLennan, Hassard 2013 These guidelines are produced by the Faculty of Occupational Medicine. The Faculty of Occupational Medicine is the professional and educational body for occupational medicine in the United Kingdom. It seeks to ensure the highest
Deciding About Hormone Therapy Use
www.menopause.orgmenopause. However, if you start HT further from menopause or after age 60, HT might slightly increase your risk of heart disease. Although there are risks associated with taking HT, they are not common, and most go away after you stop treatment. In general, HT is associated with fewer than 2 additional harmful events per 1,000 women per year.
Life After Cancer Treatment
www.cancer.govtheir pivotal work in the area of cancer survivorship under NCI Grant No. CA63018. Facing Forward was adapted from materials used in the study, Moving Beyond Cancer. n Patricia A. Ganz, M.D., Professor, UCLA Schools of Medicine and Public Health and Division of Cancer Prevention & Control Research, Jonsson Comprehensive Cancer Center,
Treatment, Life, Work, After, Cancer, Life after cancer treatment
A GUIDE TO MANAGING MENOPAUSE AT WORK
www.cipd.co.ukMENOPAUSE AT WORK In partnership with. The CIPD is the professional body for HR and people development. The registered charity champions better work and working lives and has been setting the benchmark for excellence in people and organisation development for more than 100 years. It has more than 150,000 members
ICF Checklist revSep2003 - WHO
www.who.intpre-menarche or post-menopause age). Short List of Body Functions Qualifier b1. MENTAL FUNCTIONS b110 Consciousness b114 Orientation (time, place, person) b117 Intellectual ( incl. Retardation, dementia) b130 Energy and drive functions b134 Sleep b140 Attention b144 Memory b152 Emotional functions b156 Perceptual functions b164 Higher level ...